Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Maidment

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
BJGP Open|November 14, 2025
Pharmacist-led osteoporosis review: perceptions of current practice, care gaps and implementation challengesAndrew Sturrock, Meaghan Grabrovaz, Laurna Bullock, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|July 28, 2025
Non-pharmacologicaL InterVEntions for Antipsychotic-Induced Weight Gain (RESOLVE) in People Living With Severe Mental Illness: A Realist SynthesisMaura MacPhee, Jo Howe, Hafsah Habib, et al.
BMC Geriatrics|October 23, 2019
Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort studyCarlota M Grossi, Kathryn Richardson, Chris Fox, et al.
Journal of Alzheimer'S Disease : JAD|March 3, 2020
Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug UseKathryn Richardson, Stephen B Wharton, Carlota M Grossi, et al.
Pilot and Feasibility Studies|May 1, 2026
An open-label, clinical feasibility study of the efficacy of Remdesivir for Long-COVIDHelen Neilens, Victoria Allgar, Kayle-Anne Sands, et al.
American Journal of Epidemiology|May 22, 2019
History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control StudyKathryn Richardson, Katharina Mattishent, Yoon K Loke, et al.
BMJ (Clinical Research Ed.)|April 27, 2018
Anticholinergic drugs and risk of dementia: case-control studyKathryn Richardson, Chris Fox, Ian Maidment, et al.
Pilot and Feasibility Studies|March 6, 2026
TaIlored ManagEment of Sleep (TIMES) for people with dementia and mild cognitive impairment in primary care in England: protocol for a feasibility cluster-randomised controlled trialJayden van Horik, Louise Allan, Aidin Aryankhesal, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 18, 2024
Sleep disturbance in people living with dementia or mild cognitive impairment: a realist review of general practiceAidin Aryankhesal, Jessica Blake, Geoff Wong, et al.
BMJ Open|November 18, 2022
Understanding primary care diagnosis and management of sleep disturbance for people with dementia or mild cognitive impairment: a realist review protocolLeanne Greene, Aidin Aryankhesal, Molly Megson, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
BJGP Open|November 14, 2025
Pharmacist-led osteoporosis review: perceptions of current practice, care gaps and implementation challengesAndrew Sturrock, Meaghan Grabrovaz, Laurna Bullock, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|July 28, 2025
Non-pharmacologicaL InterVEntions for Antipsychotic-Induced Weight Gain (RESOLVE) in People Living With Severe Mental Illness: A Realist SynthesisMaura MacPhee, Jo Howe, Hafsah Habib, et al.
BMC Geriatrics|October 23, 2019
Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort studyCarlota M Grossi, Kathryn Richardson, Chris Fox, et al.
Journal of Alzheimer'S Disease : JAD|March 3, 2020
Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug UseKathryn Richardson, Stephen B Wharton, Carlota M Grossi, et al.
Pilot and Feasibility Studies|May 1, 2026
An open-label, clinical feasibility study of the efficacy of Remdesivir for Long-COVIDHelen Neilens, Victoria Allgar, Kayle-Anne Sands, et al.
American Journal of Epidemiology|May 22, 2019
History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control StudyKathryn Richardson, Katharina Mattishent, Yoon K Loke, et al.
BMJ (Clinical Research Ed.)|April 27, 2018
Anticholinergic drugs and risk of dementia: case-control studyKathryn Richardson, Chris Fox, Ian Maidment, et al.
Pilot and Feasibility Studies|March 6, 2026
TaIlored ManagEment of Sleep (TIMES) for people with dementia and mild cognitive impairment in primary care in England: protocol for a feasibility cluster-randomised controlled trialJayden van Horik, Louise Allan, Aidin Aryankhesal, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 18, 2024
Sleep disturbance in people living with dementia or mild cognitive impairment: a realist review of general practiceAidin Aryankhesal, Jessica Blake, Geoff Wong, et al.
BMJ Open|November 18, 2022
Understanding primary care diagnosis and management of sleep disturbance for people with dementia or mild cognitive impairment: a realist review protocolLeanne Greene, Aidin Aryankhesal, Molly Megson, et al.
Pageof 9